Patents Assigned to ENA THERAPEUTICS PTY LTD
  • Immunostimulatory method
    Patent number: 11351114
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: June 7, 2022
    Assignee: ENA THERAPEUTICS PTY LTD
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng
  • Immunostimulatory method
    Patent number: 10406100
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Grant
    Filed: May 16, 2017
    Date of Patent: September 10, 2019
    Assignee: ENA THERAPEUTICS PTY LTD
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng